SEPTEMBER 30: PROSTABLOG NZ: A minor matter for the record – as of today, the author of this blogsite, Jim Tucker, is no longer a member of the board of the Prostate Cancer Foundation of NZ. READ MORE>
SEPTEMBER 30: PROSTABLOG NZ: Why would anyone say that getting prostate cancer was actually good for them? READ MORE>
SEPTEMBER 30: INSCIENCES: Death from prostate cancer does not vary greatly between men who undergo annual PSA screening and those who do not, according to an investigation of PSA outcomes published in the Archives on Internal Medicine today. READ MORE>
SEPTEMBER 30: DRUGS.COM: Most men are not being told the pros and cons of PSA tests, two new studies find. READ MORE>
SEPTEMBER 30: DAILY MAIL: A new treatment for treating prostate cancer – based on cells taken from the patient in the hope these will provoke the immune system into attacking and eventually killing the cancer -is being tested on men in the advanced stages of the disease. READ MORE>
SEPTEMBER 30: URO TODAY: In a Finnish study, an association between insulin level and prostate cancer risk was observed among leaner men and among men who were less physically active at work. READ MORE>
SEPTEMBER 29: WHITIREIA journalism student CARL SUURMOND went to the Chatham Islands with the Prostate Cancer Foundation last weekend. Here’s his first report: CLICK HERE>
SEPTEMBER 29: WALL STREET JOURNAL: A new study raises the question of whether patients facing prostate screening and their health-care professionals are engaging in shared decision making, and what such a collaboration should look like. READ MORE>
SEPTEMBER 29: PROSTABLOG NZ: While the NZ prostate community is mounting its latest bid to have a publicly funded awareness campaign, the Ministry of Health has today published its latest guidelines on the treatment of breast cancer. READ MORE>
SEPTEMBER 29: URO TODAY: Non-nerve sparing radical prostatectomy is more likely to lead to early development of venous leak, increased prevalence of venous leak, and reduction in return of natural erections. Nearly half the men in a study who had bilaterial nerve sparing surgery had recovered erectile function after 18 months. READ MORE>
SEPTEMBER 29: OTTAWA CITIZEN: Researchers say a microchip developed at the University of Toronto could change how cancer and infectious diseases are diagnosed, allowing doctors to conduct quicker and less invasive testing. READ MORE>
SEPTEMBER 29: SCIENCE CODEX: The largest single-institution study of its kind has found few complications in prostate cancer patients treated with radiotherapy after surgery to remove the prostate. Men in this study received radiotherapy after a PSA test following surgery indicated their cancer had recurred. READ MORE>
SEPTEMBER 29: HULIQ NEWS: Prostate cancer patients of low socio-economic status are more likely to die than patients with higher incomes, according to a new study from Swiss researchers. READ MORE>
SEPTEMBER 29: BUZZ MACHINE: Media blogger Jeff Jarvis has had great news from his medics after analysis of his prostate following removal – but his doctor is unwise to tell him he’s cured. READ MORE>
SEPTEMBER 29: URO TODAY: For some men, trying to get an erection is a major problem – but for others there is the opposite problem. Researchers at Rush University Medical Center, Chicago, have been testing a treatment for what’s called recurrent ischemic priapism, or sleep-related erections. READ MORE>
SEPTEMBER 28: PROSTABLOG NZ: New hostilities have erupted in Australia in the long-running testing-for-prostate cancer war of words. READ MORE>
SEPTEMBER 28: PROSTABLOG NZ: A Chatham Island gale whips up the tail feathers on a passing Weka – but men on the island were far from ruffled by the visit of the NZ Prostate Cancer Foundation team last weekend. READ MORE>
SEPTEMBER 27: PROSTABLOG NZ: Men on the isolated Chathams – 10 small islands 800km east of NZ – are getting the message about prostate cancer this weekend. READ MORE>
SEPTEMBER 27: AAFP NEWS NOW: Men shouldn’t just rush in to get screened for prostate cancer, says a US family doctor’s organisation – they need to talk it over with their physician first. READ MORE>
SEPTEMBER 26: MEDICAL NEWS TODAY: Nearly of 300 of the world’s leading researchers focused on the problem of prostate cancer are meeting in Nevada to discuss the latest scientific data and breakthroughs in prostate cancer. READ MORE>
SEPTEMBER 26: URO TODAY: Osteopathic treatment can be considered a genuine alternative to the conventional treatment of chronic prostatitis and chronic pelvic pain syndrome, and a closer co-operation between urologists/internists and osteopaths would be desirable. READ MORE>
SEPTEMBER 26: WALL STREET JOURNAL: Dendreon Corp expects to file for marketing approval for advanced prostate cancer immunotherapy treatment Provenge in mid-November and hopes to get final FDA approval in the middle of next year. READ MORE>
SEPTEMBER 26: URO TODAY: Factors used to predict a man’s likelihood of surviving prostate cancer change significantly if biochemical recurrence occurs – and his outlook is less favourable if he had low PSA when initially diagnosed, the time to recurrence is short and PSA doubling time is rapid. READ MORE>
SEPTEMBER 26: URO TODAY: Prostate cancer patients who wish to increase their odds of retaining sexual function might be counselled to choose external beam radiation therapy over cryoablation (freezing), a new freezing suggests. READ MORE>
SEPTEMBER 25: MEDICAL NEWS TODAY: A phase 3 clinical trial of the investigational drug MDV3100 for advanced prostate cancer has just begun in the US. READ MORE>
SEPTEMBER 25: URO TODAY: High birth weight is associated with an increased risk of prostate cancer, according to analysis of twins in Sweden. READ MORE>
SEPTEMBER 25: URO TODAY: Men with a family history may benefit from targeted communication about the risks and benefits of prostate cancer testing that responds to the implications of their heightened risk. READ MORE>
SEPTEMBER 25: URO TODAY: A moderate amount of exercise most days of the week may contribute to a lower risk of prostate cancer, and lower grade tumors among those men who are diagnosed with the disease following biopsy. READ MORE>
SEPTEMBER 25: URO TODAY: Genetic risk of prostate cancer can be reduced by rescuing critical immune system cells, a new study from the University of Michigan Comprehensive Cancer Center suggests. READ MORE>
SEPTEMBER 24: NZPA: An Otago University researcher has criticised a call by the Urological Society of Australia and New Zealand for PSA testing to be offered men aged 40. READ MORE>
SEPTEMBER 24: PROSTABLOG NZ: The NZ Health Select Committee has asked the NZ Prostate Cancer Foundation to send any cases it knows about of men being declined prostate cancer tests by doctors to the Health and Disability Commissioner. READ MORE>
SEPTEMBER 24: ABC7 NEWS: Increased levels of vitamin B6 may improve survival rates for prostate cancer, a new study suggests. The findings in the American Journal of Clinical Nutrition do not prove, but suggest, there is a protective effect. READ MORE>
SEPTEMBER 24: BUZZ MACHINE: It has been a week and a half since my prostate surgery and I’m doing great, writes media blogger Jeff Jarvis. READ MORE>
SEPTEMBER 24: NEW PROSTATE CANCER INFOLINK: Intermittent hormone therapy seems to be as effective as combined androgen deprivation, while showing greater tolerability and other quality of life advantages, especially recovery of sexual potency. READ MORE>
SEPTEMBER 24: NEW PROSTATE CANCER INFOLINK: A key goal of the prostate cancer research community has been the identification of markers that could help us to better identify patients at high risk for prostate cancer progression as early as possible in the disease process.
It now appears that the presence of an enzyme called HYAL-1 hyaluronidase and hyaluronic acid staining in prostatectomy specimens may be able to do this. READ MORE>
SEPTEMBER 24: NEW PROSTATE CANCER INFOLINK: Jonathon Epstein, MD, at Johns Hopkins is widely considered to be one of the pre-eminent prostate cancer pathologists in the world today, so it is worth listening when he says that the Gleason grading system needs revision. READ MORE>
SEPTEMBER 24: NEW PROSTATE CANCER INFOLINK: Men with organ-confined, Gleason score 6 (no pattern 4) prostate cancer can be told that their risk of progression is very rare, according to new research from Johns Hopkins Hospital. READ MORE>
SEPTEMBER 24: URO TODAY: Some 91% of 5000 German men surveyed six years after they had a radical prostatectomy, were so satisfied with the result they would recommend the operation to a friend. READ MORE>
SEPTEMBER 23: AP: A common treatment for prostate cancer may slightly increase patients’ risk of heart problems, new research says. READ MORE>
SEPTEMBER 23: STUFF: The age at which men are recommended to have their first prostate cancer test has been reduced from 50 to 40 years-old. The recommendation has come from the Urological Society of Australia and New Zealand. READ MORE>
SEPTEMBER 23: PROSTABLOG NZ: The battle lines were drawn at today’s first hearing of the NZ Parliamentary inquiry into prostate cancer – “vested interests” versus those who guard the country’s public medical system. READ MORE>
SEPTEMBER 22: PROSTABLOG NZ: Mary and John -whose prostate cancer story appears on this website – will get their 15 minutes of fame tomorrow before the first hearing of the NZ Parliament’s inquiry into the disease. READ MORE>
SEPTEMBER 22: URO TODAY: An innovative drug-delivery system — nanoparticles encapsulating nitric oxide or prescription drugs — shows promise for treatment of erectile dysfunction, according to a new study by scientists at Albert Einstein College of Medicine of Yeshiva University. READ MORE>
SEPTEMBER 22: PRIVATE HEALTH CARE UK: A researcher suggests that if a prostate cancer tumour could be fed medication instead of blood then it could be reduced in size and kept at bay. READ MORE>
SEPTEMBER 22: INDEPENDENT: Scientists are close to identifying which men are at highest risk of contracting prostate cancer after discovering a host of genetic variations that contribute to the disease. READ MORE>
SEPTEMBER 21: DOMINION POST: In this personal account, a Lower Hutt man recalls the dire effects on his life of an enlarged prostate – and how he finally got it fixed. READ MORE>
SEPTEMBER 21: PROSTABLOG NZ: Some 600 blue crosses will be positioned at the Te Papa Museum in Wellington this Friday at Te Papa Museum to remember the 600 men who die every year of prostate cancer. READ MORE>
SEPTEMBER 20: WHYY PUBLIC BROADCASTER: Men as young as 35 are being offered free screenings for prostate cancer at a Philadelphia cancer centre, but the American Cancer Society doesn’t think that’s a good idea. HEAR MORE>
SEPTEMBER 20: REUTERS: Surgeons are increasingly turning to high-tech robotic equipment to operate on patients with prostate cancer and other conditions, but some medical authorities worry about inadequate training and lax standards among practitioners. READ MORE>
SEPTEMBER 19: NEW PROSTATE CANCER INFOLINK: It may well take another 15 years before we can collect enough data to demonstrate with any degree of conviction that proton beam radio-therapy is a valuable form of treatment for localised prostate cancer. READ MORE>
SEPTEMBER 19: PROSTABLOG NZ: Brian Sargent has now reached Dunedin in his NZ prostate Cancer Foundation fund-raising tractor trek aground the South Island. READ MORE>
SEPTEMBER 19: US PROSTATE CANCER FOUNDATION: Proclamations like President Obama’s will help the US Prostate Cancer Foundation build awareness and support for finding better treatments and cures for prostate cancer. READ MORE>
SEPTEMBER 19: TIME: In the largest analysis of its kind, new research pinpoints how long older men who are diagnosed with early-stage prostate cancer can expect to live if they opt for a conservative, “watchful waiting” approach to their cancer treatment — as opposed to seeking immediate, aggressive therapies such as surgery and radiation. READ MORE>
SEPTEMBER 19: SOA WORLD MAGAZINE: A coalition of influential European advocacy and professional groups wants action by the European Parliament to commit to serious steps to reduce the number of men affected by and dying from prostate cancer by ensuring timely access to information, care and support services for men at risk or with prostate cancer. READ MORE>
SEPTEMBER 19: URO TODAY: There is no evidence that tumour volume is an independent predictor of prostate cancer outcome and it should not be considered as a marker of tumour risk, behaviour or prognosis. READ MORE>
SEPTEMBER 19: DOMINION POST: Prostate cancer patients are being offered faster, more targeted and more effective treatment with the introduction of a high-dose radiation therapy at Wellington Hospital. READ MORE>
SEPTEMBER 18: URO TODAY: Cannabinoids really do show promise in inhibiting the growth of prostate cancer tumours, according to further research by scientists in Madrid. READ MORE>
SEPTEMBER 18: THE WELLINGTONIAN: A story and picture reporting Sunday’s Blue September dawn walk appear in today’s edition of one of the Wellington city community newspapers, The Wellingtonian. Big thanks to editor Joseph Romanos. READ MORE>
SEPTEMBER 18: URO TODAY: A new study has examined the reliability of tadalafil once daily (that is, successful attempts/total attempts) following initial successful intercourse. READ MORE>
SEPTEMBER 18: BUZZ MACHINE: Top new media blogger Jeff Jarvis describes his very recent prostate cancer surgery: READ MORE>
SEPTEMBER 18: URO TODAY: Taking non-steroidal anti-inflammatory drugs may reduce the risk of prostate cancer, but the effect is small. READ MORE>
SEPTEMBER 18: URO TODAY: Scientists in Texas have been analysing data on the considerable number of castration-refractory prostate cancer patients who experience an initial PSA surge/flare-up while having chemotherapy. READ MORE>
SEPTEMBER 18: URO TODAY: Measuring DNA in prostate cancer tissue samples and samples from adjacent benign areas helps predict if treatment for low-grade disease will be needed. READ MORE>
SEPTEMBER 18: URO TODAY: US men diagnosed with prostate cancer in the early 1990s have had significantly better survival rates compared with patients diagnosed in prior decades. READ MORE>
SEPTEMBER 18: ATLANTA INTERNET MARKETING: Is actor George Clooney tempting fate when he says: “I would rather have a prostate exam on live television by a guy with very cold hands than have a Facebook page.” READ MORE>
SEPTEMBER 18: URO TODAY: The Japanese – who already have lower prostate cancer rates than Westerners – are reviewing their policy on population-based screening. READ MORE>
SEPTEMBER 18: MEDICAL NEWS TODAY: A new type of cancer drug called PARP inhibitors – including a new drug called olaparib that is currently showing promising results in trials as a targeted treatment for inherited forms of breast and ovarian cancer - may also be effective against prostate cancer. READ MORE>
SEPTEMBER 18: ONCOLOGY STAT: A second investigational vaccine has shown a significant survival advantage in men with asymptomatic metastatic castration-resistant prostate cancer. READ MORE>
SEPTEMBER 16: IHEALTH BULLETIN NEWS: Omega-3 fatty acids and lignan present in flaxseed led researchers to look at flaxseed’s prostate cancer prevention properties. READ MORE>
SEPTEMBER 16: NEW PROSTATE CANCER INFOLINK: Appropriate use of radiation therapy on prostate cancer patients whose tumour has spread to the margins is still unresolved. READ MORE>
SEPTEMBER 16: NEW PROSTATE CANCER INFOLINK: Either maximal androgen blockade or hormonal monotherapy are reasonable choices for use in combination with brachytherapy in the management of men with intermediate- or high-risk prostate cancer, a retrospective study finds. READ MORE>
SEPTEMBER 16: URO TODAY: Erectile dysfunction following treatment for prostate cancer – particularly radical prostatectomy – is a major quality of life issue that remains unsatisfactorily addressed. Here’s a new look at the issues. READ MORE>
SEPTEMBER 16: URO TODAY: A phase III clinical trial will go ahead to evaluate toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, a pre-cancerous lesion of the prostate. READ MORE>
SEPTEMBER 15: PROSTABLOG NZ: Those turning up for the first day of hearings at the inquiry into prostate cancer need to check first, because the NZ Parliament has gone into urgent session, meaning all meetings will be delayed or postponed.
SEPTEMBER 15: PROSTABLOG NZ: One of the icons of this year’s Blue September prostate awareness campaign – former All Black captain Buck Shelford (left)- will be in Porirua early this Friday at a fund-raising barbeque. READ MORE>
SEPTEMBER 15: TRAVELSOCIETYBLOG.COM: The potent metabolite of vitamin D, calcitriol, and other vitamin D analogues are chemo-preventive agents that may prevent prostate cancer. READ MORE>
SEPTEMBER 15: COMPARE BEAST.COM: Former tennis star John McEnroe, a prominent new US campaigner for prostate cancer testing, is being paid for his efforts by the pharmaceutical giant GlaxoSmithKline—which just happens to make dutasteride (Avodart), a prostatemedication. READ MORE>
SEPTEMBER 15: MEDICAL NEWS TODAY: Body mass in younger and older adulthood, and weight gain between these life periods, may influence a man’s risk for prostate cancer. READ MORE>
SEPTEMBER 15: URO TODAY: How many times is too many when it comes to getting up in the night to pee? A study of 6000 Finns gives some predictable answers. READ MORE>
SEPTEMBER 15: URO TODAY: Successful isolation of circulating tumour cells from peripheral whole blood is a fairly recent development that offers the potential to further characterise and understand advanced prostate cancer. READ MORE>
SEPTEMBER 15: URO TODAY: Under-arm anti-perspirants may be a culprit in prostate and breast cancer – find out how in this clearly written analysis: READ MORE>
SEPTEMBER 15: URO TODAY: Testicular prostheses that slow-release drugs to combat bone loss in men being treated for advanced prostate cancer, have the potential to restore testes removal as a viable option for testosterone control. READ MORE>
SEPTEMBER 15: URO TODAY: Studies are needed to better delineate how active surveillance can be used to reduce over-treatment and optimise quality of life, while maintaining the survival benefits of selective treatment. READ MORE>
SEPTEMBER 14: PROSTABLOG NZ: A chance meeting between two Maori men may affect the future well-being of 135 males living on the Chatham Islands. READ MORE>
SEPTEMBER 13: URO TODAY: A new Japanese risk assessment system that ranks advanced prostate cancer patients out of 12 on Gleason score, PSA level, and clinical stage is the first for men undergoing primary androgen deprivation therapy. READ MORE>
SEPTEMBER 13: ABC NEWS: Prostate size affects the technical difficulty of radical prostatectomy but not the functional results. READ MORE>
SEPTEMBER 13: URO TODAY: Men who start erectile function rehab at six months after prostate cancer surgery do better than those who delay it beyond that time, according to a new study. For the purposes of the study, six months was regarded as “early” rehab. READ MORE>
SEPTEMBER 13: URO TODAY: PSA screening reduces the risk of dying of prostate cancer by up to 31% in men actually screened, and this benefit should be weighed against a degree of over-diagnosis and over-treatment inherent in prostate cancer screening. This finding comes from deeper analysis of the large randomised European study reported earlier this year. READ MORE>
SEPTEMBER 13: URO TODAY: Psychological distress and pain are commonly experienced after prostate cancer surgery, and both can contribute to suppression of the immune response to cancer. READ MORE>
SEPTEMBER 13: PROSTABLOG NZ: Dozens turned out to a perfect Wellington dawn today to walk in remembrance of those who have died from prostate cancer. READ MORE>
SEPTEMBER 13: URO TODAY: More US men were diagnosed with prostate cancer at a younger age and earlier stage in 2004-2005 than in earlier years and the racial disparity in cancer stage at diagnosis has decreased statistically significantly over time. READ MORE>
SEPTEMBER 12: PROSTABLOG NZ: Maori and Pacific people living in NZ suffer big disparities in the way cancer is detected and treated, and how well they survive it. READ MORE>
SEPTEMBER 11: PROSTABLOG NZ: MP Paul Hutchison – chair of the upcoming Parliamentary inquiry into prostate cancer – is making no secret of where his sympathies lie when it comes to increasing awareness of the disease.
SEPTEMBER 11: PROSTABLOG NZ: New guidelines for general practitioners on how to handle men presenting with possible symptoms of prostate cancer were released today by the NZ Ministry of Health. READ MORE>
SEPTEMBER 11: MEDICAL NEWS TODAY: Despite tremendous advances in delivery of radiation recently, rectal bleeding remains a common and potentially serious side effect of radiation. READ MORE>
SEPTEMBER 11: MEDICAL NEWS TODAY: Many men at risk for the cancer still aren’t aware of all available treatment options, a new survey suggests. READ MORE>
SEPTEMBER 11: URO TODAY: Men with low-risk prostate cancer who are candidates for active surveillance often choose definitive therapy due to anxiety over their untreated cancer. READ MORE>
SEPTEMBER 11: TIMES ONLINE: It is probably the most delicious cancer treatment yet devised – a recipe book built around foods known to help to fight prostate cancer is the first example of “evidence-based cooking”. READ MORE>
SEPTEMBER 11: LA TIMES: Men infected with the sexually transmitted bacterium Trichomonas vaginalis have a slightly increased risk of developing prostate cancer and double the normal risk of developing the aggressive form of the disease. READ MORE>
SEPTEMBER 11: URO TODAY: Wide-spread population screening for prostate cancer carries several ethical, social, and psychological implications, which might overwhelm the potential benefits, say researchers at the Clinical Chemistry Section, University-Hospital of Verona, Italy. READ MORE>
SEPTEMBER 11: URO TODAY: Electrical properties of the prostate may provide sufficient contrast for distinguishing malignant and benign formations, reports the Thayer School of Engineering, Dartmouth College, in New Hampshire. READ MORE>
SEPTEMBER 10: BUZZ MACHINE: “As I prepare to go under the robot on Monday, I’ve found that the process includes drugstore embarrassments. They’ve only just begun,” writes Jeff Jarvis four days out from his prostatectomy. READ MORE>
SEPTEMBER 10: BREAKTHROUGH DIGEST MEDICAL NEWS: A new type of stem cell discovered in the prostate of adult mice can be a source of prostate cancer, according to a new study. READ MORE>
SEPTEMBER 10: DRUGS.COM: Two studies take significant steps toward solving major mysteries about prostate cancer – the exact spot in the gland where tumors can originate, and how to distinguish fast-growing malignancies that are life-threatening from the slower-growing kind. READ MORE>
SEPTEMBER 10: NEW PROSTATE CANCER INFOLINK: A new study appears to confirm that transperineal three-dimensional prostate mapping biopsies can be used with a high level of safety to accurately stage appropriately selected prostate cancer patients. READ MORE>
SEPTEMBER 10: NEW ENGLAND JOURNAL OF MEDICINE: Some 350 cancer genes have so far been identified by researchers, but there may be as many as 2000, says Dr James R Downing, Memphis, in an analysis of cancer genome research. READ MORE>
SEPTEMBER 9: NEW PROSTATE CANCER INFOLINK: The prostate “wires” are dominated by one story today – the claim a virus might be linked to the most aggressive forms of prostate cancer. But NPCI’s Mike Scott cautions this kind of finding has been touted before and more evidence is needed. READ MORE>
SEPTEMBER 9: PROSTABLOG NZ: NZ cancer patients have “responded in droves to a first-of-its-kind survey” exploring patient experiences of cancer care, says a media release from the Cancer Control Council of NZ. READ MORE>
SEPTEMBER 9: URO TODAY: The early use of phosphodiesterase inhibitors after radiotherapy for prostate cancer probably reduces the risk of erectile dysfunction. READ MORE>
SEPTEMBER 9: URO TODAY: Emerging urine tests should help in both early diagnosis of prostate cancer and identifying aggressive tumors for radical treatment. READ MORE>
SEPTEMBER 9: URO TODAY: A computer-aided diagnostic system has been developed for the discrimination of normal, infectious and cancer prostate tissues based on texture analysis of transrectal ultrasound images. READ MORE>
SEPTEMBER 9: CLEVELAND CLINIC: Two large trials of screening with prostate-specific antigen measurements came to seemingly opposite conclusions. READ MORE>
SEPTEMBER 9: PROSTABLOG NZ: A dawn walk organised by the Prostate Cancer Foundation will start from Wellington’s Freyberg Pool on Oriental Pde at 7am this Sunday (September 13).
SEPTEMBER 8: REUTERS: Two big European drug companies have concluded a deal to develop and sell Debio 0931, which inhibits the growth of tumours in cancers like prostate cancer.
SEPTEMBER 8: GUARDIAN: Scientists working on prostate cancer have found evidence that the most aggressive forms of the disease may be caused by a virus. READ MORE>
SEPTEMBER 7: PROSTABLOG NZ: A new $20 million “Maori health innovations fund” has been announced by the Associate Minister of Health, Tariana Turia – but it makes no mention of one of the biggest killers of Maori men, prostate cancer. READ MORE>
SEPTEMBER 7: URO TODAY: African American men have a less satisfactory experience than Caucasians when dealing with medical professionals over prostate cancer, a study of more than 1000 men has found. READ MORE>
SEPTEMBER 6: PROSTABLOG NZ: When global mainstream media reported the recent (partial) success of Dendreon drug company getting FDA approval for its new immunotherapy prostate cancer drug, it didn’t mention the machinations of the drug’s tortuous path to the chemist shop.
SEPTEMBER 6: NORWAY POST: Alpharadin, a new drug that treats men with hormone-refractory prostate cancer that has spread to the bone, will be developed by a Norwegian cancer therapeutics company and global drugs giant Bayer. READ MORE>
SEPTEMBER 6: URO TODAY: Researchers in Canada have reviewed the vast range of drugs now being used to treatment prostate cancer. READ MORE>
SEPTEMBER 6: URO TODAY: High levels of testosterone have until recently been regarded as dangerous for prostate cancer patients, but new evidence is emerging that suggests something different. READ MORE>
SEPTEMBER 6: URO TODAY: A technique for restoring the position of the urethra during radical prostatectomy – using a suture with a figure-of-eight knot – restores continence more quickly. READ MORE>
SEPTEMBER 5: MODERN MEDICINE: Some men with prostate cancer may safely defer treatment for years without a higher risk of metastasis or cancer mortality than those who receive initial treatment. This, according to research published in the Journal of Clinical Oncology, which also says it may not apply to younger men and those with high PSA. READ MORE>
SEPTEMBER 5: URO TODAY: Increased expression of a protein called vascular endothelial growth factor-C (VEGF-C) protects some prostate cancer cells from treatment and boosts tumour recurrence and spread, Mayo Clinic researchers have discovered. READ MORE>
SEPTEMBER 5: SCIENCE-CENTRIC.COM: A study of prostate risk factors in Japanese men seems to reinforce the idea that discovered variants are often simply population-specific markers that need far more study to confirm as functional culprits. READ MORE>
SEPTEMBER 5: JAZBA.COM: Too much calcium in the bloodstream may signal increased risk of fatal prostate cancer, according to a new analysis from Wake Forest University and University of Wisconsin. READ MORE>
SEPTEMBER 5: ARTICLE BLISS.COM: Men who eat more than 10 servings of tomato-based foods daily (such as cooked tomatoes and tomato sauce, V8 juice) have a 35% lower risk of developing prostate cancer. READ MORE>
SEPTEMBER 4: PROSTABLOG NZ: Two top NZ prostate cancer experts were today appointed to a completely renewed Cancer Control Council, which gives expert advice to the Ministry of Health. READ MORE>
SEPTEMBER 4: EXPERT CLICK.COM: Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy over traditional external beam radiation therapy, because IGRT corrects for prostate shifts, which, if not planned for, can lead to incorrect doses of radiation to the disease site. READ MORE>
SEPTEMBER 4: PROSTABLOG NZ: The US government – like all governments, including NZ’s – doesn’t approve of population-based prostate cancer screening, but that doesn’t seem to stop various organisations in the US offering screening. READ MORE>
SEPTEMBER 4: PITTSBURGH TRIBUNE-REVIEW: A Johns Hopkins researcher and the University of Pittsburgh committed more than five years of prostate cancer research fraud, a privately owned biotechnology company alleges in a lawsuit. READ MORE>
SEPTEMBER 4: URO TODAY: Men the world over may be much the same – most don’t perceive themselves at risk from prostate cancer and don’t seek screening tests. A US study has looked at whether this outlook varies between races. READ MORE>
SEPTEMBER 4: URO TODAY: US scientists have successfully tested a new DNA vaccine that significantly slows PSA doubling, the signal of a belated return of prostate cancer after treatment. READ MORE>
SEPTEMBER 4: URO TODAY: Few patients – an average 12% – will die from prostate cancer within 15 years of radical prostatectomy, concludes a study of nearly 13,000 US patients. The death rate ranges from 5% for low-risk cancer to 38% for high-risk. READ MORE>
SEPTEMBER 4: URO TODAY: Forty percent of about 400 men treated with brachytherapy developed urinary obstructive symptoms, generally within the first three to six months, according to a study of about 400 prostate cancer patients. READ MORE>
SEPTEMBER 4: URO TODAY: Dutch researchers have looked at the way prostate cancer patients who choose “active surveillance” are affected by psychological, medical, demographic, and decision-related factors. READ MORE
SEPTEMBER 4: URO TODAY: Younger men with high-risk prostate cancer appear to have worse prognosis than older men with similar disease, according to a study of 4000 men receiving hormone treatment. READ MORE>
SEPTEMBER 4: URO TODAY: Overall survival for African American advanced prostate cancer patients versus all other patients was 6% versus 9%, according to analysis of data involving nearly 20,000 US cancer patients treated between between 1974 and 2001. READ MORE>
SEPTEMBER 3: THE GOV MONITOR: The Australian Government last year committed $15 million over five years from 2008-09 to establish two dedicated prostate cancer research centres in Australia. READ MORE>
SEPTEMBER 3: PR NEWSWIRE.COM: Compared with surgery, brachytherapy (radiation seed implants) is proving to have a superior disease-free survival rate for patients with early stage prostate cancer,according to two studies in the US. READ MORE>
SEPTEMBER 3: EUREKALERT.ORG: Positron emission tomography/computer tomography scans with the imaging agent choline can detect recurring prostate cancer sooner than conventional imaging technologies in some patients after prostate surgery. READ MORE>
SEPTEMBER 3: UPI.COM: The disparity between African-American and white men with prostate cancer has diminished over time, US researchers have found. READ MORE>
SEPTMBER 3: URO TODAY: A pilot study in New York looked at whether barbers can be used to pass on crucial messages to their customers about the need for prostate cancer screening. READ MORE>
SEPTEMBER 2: URO TODAY: Combining analysis of genetic risk with PSA tests is likely to give more accurate assessments of prostate cancer risk, according tothe medical director of the US Urological Research Foundation. READ MORE>
SEPTEMBER 2: PR WEB: Men with prostate cancer often choose not to talk about their disease, even with spouses, and are uncomfortable about needing emotional support – but a nurse tells how they are okay talking to her. READ MORE>
SEPTEMBER 2: URO TODAY: Dietary intake of an anti-oxidant found in soy called genistein by patients with prostate cancer decreases cancer spread and death, new research confirms. READ MORE>
SEPTEMBER 2: THE GOVMONITOR.COM: “NOW, therefore, I, Barack Obama, President of the United States of America, by virtue of the authority vested in me by the Constitution and laws of the United States, do herebyproclaim September 2009 as National Prostate Cancer Awareness Month.” READ MORE>
SEPTEMBER 2: PROSTABLOG NZ: In what seems a perverse coincidence (for pro-testers), just as NZ’s Parliament begins an inquiry into prostate cancer screening and treatment, an American report casting renewed doubt about PSA testing and rectal exams has re-ignited global debate. READ MORE>
SEPTEMBER 2: DRUGS.COM: Men who pack on excess pounds as young adults are at heightened risk of developing prostate cancer, although the risk varies by ethnic group, say researchers from the University of Hawaii. READ MORE>
SEPTEMBER 2: PSA RISING.COM: Is the Lockerbie bomber really dying of prostate cancer, or was his emergency dash to hospital in the back of a police car just staged for effect? A UK TV reporting who went into the ward to find has his doubts. READ MORE>
SEPTEMBER 1: NEW PROSTATE CANCER INFOLINK: “Are we over-treating 50,000 men each year? Could it be even more?” asks Mike Scott, the sitemaster of America’s leading prostate cancer discussion website. These questions begin his analysis of an article by Welch and Albertsen in this week’s issue of the Journal of the National Cancer Institute, which estimates how much “over-treatment” may have occurred during the 20-year period from 1986 and 2005. READ MORE>
SEPTEMBER 1: URO TODAY: Sunitinib malate – a chemotherapy drug usually used to fight kidney and stomach cancers – showed promising results when trialled on men with metastatic castration-resistant prostate cancer. READ MORE>
SEPTEMBER 1: PROSTABLOG NZ: The widespread confusion many men feel over the advice they receive on early detection and treatment of prostate cancer is untenable, says Dr Paul Hutchison, chairman of the NZ Parliamentary Health Select Committee. READ MORE>
SEPTEMBER 1: SUITE101.COM: Extract from the round, red berries of the saw palmetto plant reduced night-time urination in 73% of patients with prostate problems and improved urinary flow rates significantly, according to a three-year German study. READ MORE>
This page has the following sub pages.
Solid information, many thanks to the writer. It is unexplainable to me now, but in general, the usefulness and significance is overwhelming. Very much thanks again and goodluck!